DE69934097D1 - Flüssige orale formulierungen von benzoxazinonen enthaltenden hiv reverse transkriptase hemmern - Google Patents

Flüssige orale formulierungen von benzoxazinonen enthaltenden hiv reverse transkriptase hemmern

Info

Publication number
DE69934097D1
DE69934097D1 DE69934097T DE69934097T DE69934097D1 DE 69934097 D1 DE69934097 D1 DE 69934097D1 DE 69934097 T DE69934097 T DE 69934097T DE 69934097 T DE69934097 T DE 69934097T DE 69934097 D1 DE69934097 D1 DE 69934097D1
Authority
DE
Germany
Prior art keywords
benzoxazinones
reverse transcriptase
oral formulations
transcriptase inhibitors
liquid oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934097T
Other languages
English (en)
Other versions
DE69934097T2 (de
Inventor
M Bahal
B Maurin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of DE69934097D1 publication Critical patent/DE69934097D1/de
Application granted granted Critical
Publication of DE69934097T2 publication Critical patent/DE69934097T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69934097T 1998-02-17 1999-02-17 Flüssige orale formulierungen von benzoxazinonen enthaltenden hiv reverse transkriptase hemmern Expired - Lifetime DE69934097T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7488198P 1998-02-17 1998-02-17
US74881P 1998-02-17
PCT/US1999/003318 WO1999040921A2 (en) 1998-02-17 1999-02-17 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors

Publications (2)

Publication Number Publication Date
DE69934097D1 true DE69934097D1 (de) 2007-01-04
DE69934097T2 DE69934097T2 (de) 2007-06-28

Family

ID=22122226

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934097T Expired - Lifetime DE69934097T2 (de) 1998-02-17 1999-02-17 Flüssige orale formulierungen von benzoxazinonen enthaltenden hiv reverse transkriptase hemmern

Country Status (19)

Country Link
US (1) US6235733B1 (de)
EP (1) EP1054674B1 (de)
JP (1) JP2002502878A (de)
CN (1) CN1170541C (de)
AR (1) AR018092A1 (de)
AT (1) ATE345802T1 (de)
AU (1) AU745008C (de)
BR (2) BRPI9908132B8 (de)
CA (1) CA2319609C (de)
DE (1) DE69934097T2 (de)
ES (1) ES2277429T3 (de)
HK (1) HK1030749A1 (de)
HR (1) HRP990049A2 (de)
IL (1) IL137763A0 (de)
MY (1) MY139034A (de)
NZ (1) NZ506579A (de)
TW (1) TW528596B (de)
WO (1) WO1999040921A2 (de)
ZA (1) ZA99981B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019530727A (ja) * 2016-10-11 2019-10-24 オクタ ファーマシューティカルズ ラモトリギンを含む経口懸濁液用の粉末

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484281B2 (de) * 1990-11-02 2000-11-22 Novartis AG Zyklosporine
US5494936A (en) * 1992-04-27 1996-02-27 Vyrex Corporation Delivery formulation for probucol
US5519021A (en) 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
AU1694295A (en) 1994-01-28 1995-08-15 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
AU712120B2 (en) 1996-05-02 1999-10-28 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
AU4802797A (en) * 1996-10-02 1998-04-24 Du Pont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv rever se transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
BRPI9908132B8 (pt) 2016-11-16
WO1999040921A3 (en) 1999-11-04
HK1030749A1 (en) 2001-05-18
MY139034A (en) 2009-08-28
ZA99981B (en) 2000-08-08
CN1291098A (zh) 2001-04-11
HRP990049A2 (en) 1999-12-31
AU745008B2 (en) 2002-03-07
CN1170541C (zh) 2004-10-13
AR018092A1 (es) 2001-10-31
EP1054674B1 (de) 2006-11-22
TW528596B (en) 2003-04-21
BR9908132A (pt) 2000-12-05
ES2277429T3 (es) 2007-07-01
EP1054674A2 (de) 2000-11-29
NZ506579A (en) 2002-11-26
US6235733B1 (en) 2001-05-22
DE69934097T2 (de) 2007-06-28
IL137763A0 (en) 2001-10-31
AU745008C (en) 2003-03-27
WO1999040921A2 (en) 1999-08-19
CA2319609A1 (en) 1999-08-19
BRPI9908132B1 (pt) 2015-07-14
BRPI9908132C1 (pt) 2021-05-25
CA2319609C (en) 2007-09-18
ATE345802T1 (de) 2006-12-15
JP2002502878A (ja) 2002-01-29
AU2682799A (en) 1999-08-30

Similar Documents

Publication Publication Date Title
SG80631A1 (en) Inhibitors of hiv reverse transcriptase
ATE231393T1 (de) Flüssige zusammensetzung, hiv protease inhibitoren und c12-c18 fettsaure enthaltend
PT1002795E (pt) Pirimidinas inibidoras da replicacao do hiv
DE60204403D1 (de) Feste orale Dosierungsform von Simethicon
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
DK0975778T3 (da) Anvendelse af glyphostat-resistende majslinier
NO994904L (no) 4,4-disubstituerte-3,4-dihydro-2(1H)-quinazolinoner nyttig som HIV-reverstranskriptaseinhibitorer
DE60122718D1 (de) Strukturen und zusammensetzungen zur erhöhung der stabilität von aktiven peroxiden
EE04799B1 (et) Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
DK1674084T3 (da) Forlænget frigivelse af oral dosissammensætning
EE200000759A (et) Farmatseutilised kompositsioonid kahe või enama toimeainega aerosoolidele
AU1694295A (en) Benzoxazinones as inhibitors of hiv reverse transcriptase
NO20021042D0 (no) Benzofenoner som inhibitorer av revers transkriptase
KR960701010A (ko) 사람 면역결핍 바이러스(HIV) 역전사효소의 억제제(Inhibitors of HIV reverse transcriptase)
DE69928779D1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
DK1073416T3 (da) Anvendelse af NO som anti-inflammatorisk middel
ATE279114T1 (de) Dermal applizierbare wasserhaltige formulierungen von parasitiziden
NO20001585L (no) Orale sammensetninger av levosimendan
FI945199A (fi) HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit
DE69934097D1 (de) Flüssige orale formulierungen von benzoxazinonen enthaltenden hiv reverse transkriptase hemmern
KR970001332A (ko) 피리미딘화합물, 액정조성물 및 액정소자
DK0831820T3 (da) Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform
EE200300027A (et) HIV pöördtranskriptaasi inhibiitoritena kasutatavad tritsüklilised 2-püridooniühendid
ATE254453T1 (de) Oral anzuwendendes sertralinhaltiges konzentrat
ZA99978B (en) Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition